DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0015625 | Fanconi Anemia | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0033300 | Progeria | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0206687 | Carcinoma, Endometrioid | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0079731 | B-Cell Lymphomas | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1527336 | Sjogren's Syndrome | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0751295 | Memory Loss | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0007965 | Chediak-Higashi Syndrome | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C3888004 | HERMANSKY-PUDLAK SYNDROME 5 | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0004364 | Autoimmune Diseases | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C2936904 | Opitz GBBB Syndrome, X-Linked | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C1563705 | Nephrogenic Diabetes Insipidus, Type I | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C3203102 | Idiopathic pulmonary arterial hypertension | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0007137 | Squamous cell carcinoma | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0036529 | Myocardial Diseases, Secondary | PRKAA2 | 5563 | protein kinase AMP-activated catalytic subunit alpha 2 | P54646 |
C0024121 | Lung Neoplasms | ARSF | 416 | arylsulfatase F | P54793 |
C0021400 | Influenza | ARSF | 416 | arylsulfatase F | P54793 |
C0345904 | Malignant neoplasm of liver | ARSF | 416 | arylsulfatase F | P54793 |
C0376358 | Malignant neoplasm of prostate | ARSF | 416 | arylsulfatase F | P54793 |
C0007131 | Non-Small Cell Lung Carcinoma | ARSF | 416 | arylsulfatase F | P54793 |
C0024623 | Malignant neoplasm of stomach | ARSF | 416 | arylsulfatase F | P54793 |
C0027651 | Neoplasms | ARSF | 416 | arylsulfatase F | P54793 |
C0007137 | Squamous cell carcinoma | ARSF | 416 | arylsulfatase F | P54793 |
C0700095 | Central neuroblastoma | ARSF | 416 | arylsulfatase F | P54793 |
C0023524 | Leukoencephalopathy, Progressive Multifocal | ARSF | 416 | arylsulfatase F | P54793 |
C0024141 | Lupus Erythematosus, Systemic | ARSF | 416 | arylsulfatase F | P54793 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024